Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
The European respiratory journal - 61(2023), 1 vom: 01. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dhote, Théo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
126880-72-6 |
|---|
| Anmerkungen: |
Date Completed 10.01.2023 Date Revised 23.03.2023 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.1183/13993003.02096-2022 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349685746 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349685746 | ||
| 003 | DE-627 | ||
| 005 | 20231226043223.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/13993003.02096-2022 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1165.xml |
| 035 | |a (DE-627)NLM349685746 | ||
| 035 | |a (NLM)36455960 | ||
| 035 | |a (PII)2202096 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dhote, Théo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.01.2023 | ||
| 500 | |a Date Revised 23.03.2023 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a elexacaftor |2 NLM | |
| 650 | 7 | |a RRN67GMB0V |2 NLM | |
| 650 | 7 | |a ivacaftor |2 NLM | |
| 650 | 7 | |a 1Y740ILL1Z |2 NLM | |
| 650 | 7 | |a tezacaftor |2 NLM | |
| 650 | 7 | |a Cystic Fibrosis Transmembrane Conductance Regulator |2 NLM | |
| 650 | 7 | |a 126880-72-6 |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 700 | 1 | |a Martin, Clémence |e verfasserin |4 aut | |
| 700 | 1 | |a Regard, Lucile |e verfasserin |4 aut | |
| 700 | 1 | |a Pesenti, Lucie |e verfasserin |4 aut | |
| 700 | 1 | |a Kanaan, Reem |e verfasserin |4 aut | |
| 700 | 1 | |a Carlier, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Honoré, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Da Silva, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Witko-Sarsat, Véronique |e verfasserin |4 aut | |
| 700 | 1 | |a Burgel, Pierre-Régis |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European respiratory journal |d 1989 |g 61(2023), 1 vom: 01. Jan. |w (DE-627)NLM012664782 |x 0903-1936 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2023 |g number:1 |g day:01 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1183/13993003.02096-2022 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2023 |e 1 |b 01 |c 01 | ||